Literature DB >> 17256789

Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome.

Elke Wühl1, Jillene Kogan, Aleksandra Zurowska, Verena Matejas, Rene G Vandevoorde, Thomas Aigner, Olaf Wendler, Iga Lesniewska, Raymonde Bouvier, André Reis, Joachim Weis, Pierre Cochat, Martin Zenker.   

Abstract

Pierson syndrome is an autosomal recessive disorder comprising congenital nephrotic syndrome with diffuse mesangial sclerosis and distinct eye abnormalities with microcoria reported as the most prominent clinical feature. LAMB2 mutations leading to lack of laminin beta2 were identified as the molecular cause underlying Pierson syndrome. Although LAMB2 is known to be expressed in the neuromuscular system, and defects of the neuromuscular junctions had been found in laminin beta2-deficient mice, no consistent neurological phenotype has been described clinically in murine or human laminin beta2-deficiency before. This is likely due to the early lethality from renal failure. Here we provide a detailed description of neurological manifestations and development in four patients affected by Pierson syndrome, who survived until the age of 1.3-4.8 years owing to renal replacement therapy. Severe muscular hypotonia, psychomotor retardation, and blindness were present in three patients harboring truncating mutations on both LAMB2 alleles. These symptoms were not attributable to complications of chronic renal failure, thus representing a primary feature of the genetic disorder. Alterations in skeletal muscle tissue from one case were compatible with a chronic denervating process. One affected girl, however, exhibited a milder course of renal disease, normal development, and preserved vision, presumably owing to some residual LAMB2 function. Our findings indicate that severe neurodevelopmental deficits have to be considered as part of Pierson syndrome, at least in the presence of biallelic functional null mutations (complete lack of laminin beta2). This is an important issue in the counseling of parents of an affected newborn or infant. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17256789     DOI: 10.1002/ajmg.a.31564

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  23 in total

1.  Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.

Authors:  Eduardo Machuca; Geneviève Benoit; Fabien Nevo; Marie-Josèphe Tête; Olivier Gribouval; Audrey Pawtowski; Per Brandström; Chantal Loirat; Patrick Niaudet; Marie-Claire Gubler; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

2.  Cellular origins of type IV collagen networks in developing glomeruli.

Authors:  Dale R Abrahamson; Billy G Hudson; Larysa Stroganova; Dorin-Bogdan Borza; Patricia L St John
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

Review 3.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

4.  Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.

Authors:  Brooke M Steenhard; Kathryn Isom; Larysa Stroganova; Patricia L St John; Adrian Zelenchuk; Paul B Freeburg; Lawrence B Holzman; Dale R Abrahamson
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

5.  Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome.

Authors:  Jung Hee Suh; George Jarad; Rene G VanDeVoorde; Jeffrey H Miner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 6.  Developmental and pathogenic mechanisms of basement membrane assembly.

Authors:  Peter D Yurchenco; Bruce L Patton
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  Variable phenotype of Pierson syndrome.

Authors:  Hyun Jin Choi; Beom Hee Lee; Ju Hyung Kang; Hyoen Joo Jeong; Kyung Chul Moon; Il Soo Ha; Young Suk Yu; Verena Matejas; Martin Zenker; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

8.  Analysis of genes encoding laminin beta2 and related proteins in patients with Galloway-Mowat syndrome.

Authors:  Andreas Dietrich; Verena Matejas; Martin Bitzan; Seema Hashmi; Cathy Kiraly-Borri; Shuan-Pei Lin; Eva Mildenberger; Bernd Hoppe; Lars Palm; Takashi Shiihara; Jens-Oliver Steiss; Jeng-Daw Tsai; Udo Vester; Stefanie Weber; Elke Wühl; Kristina Zepf; Martin Zenker
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714

9.  A milder variant of Pierson syndrome.

Authors:  Mikhail Kagan; Arthur H Cohen; Verena Matejas; Christopher Vlangos; Martin Zenker
Journal:  Pediatr Nephrol       Date:  2007-10-18       Impact factor: 3.714

Review 10.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.